Trial Profile
Phase IV Study of the Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Quetiapine (Primary) ; Ziprasidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms PAFIP II; PAFIP2
- 10 Sep 2013 New trial record